SAN DIEGO, Aug. 29, 2022 (GLOBE NEWSWIRE) — Shareholder Rights Law Firm Johnson Fistula, LLP announces that a class action lawsuit has been filed on behalf of investors in Humanigen, Inc. (“Humanigen” or the “Company”) HGEN. The class action is being brought on behalf of shareholders who purchased or otherwise acquired Humanigen stock between May 28, 2021 and July 12, 2022, both dates inclusive (the “Class Period”). Investors are hereby notified that they have until October 25, 2022 to request the court to appear as lead plaintiff in this lawsuit.

What actions can I take at this time? If you have suffered a loss and would like to learn more about whether you are a Lead Plaintiff, please contact Jim Baker (jimb@johnsonfistula.com) via email or phone at 619-814-4471. When emailing, please include your phone number.

To participate in this promotion you can click on the following link or copy and paste it into a browser:

https://www.johnsonfistel.com/investigations/humanigen-hgen-fda-activ-5-class-action

There are no costs or obligations for you.

The Complaint alleges that the Defendants made materially false and misleading statements about the Company’s business, operations and prospects throughout the Class Period. In particular, the Defendants made false and/or misleading claims and/or failed to disclose that: (i) lenzilumab was less effective in treating hospitalized COVID-19 patients than the Defendants had argued; (ii) as a result, the FDA was unlikely to approve the lenzilumab EUA and the ACTIV-5/BET-B study was unlikely to meet its primary endpoint; (iii) accordingly, the clinical and commercial prospects of lenzilumab have been overstated; and (iv) as a result, the Company’s public statements were, at all relevant times, materially false and misleading.

A lead plaintiff will act on behalf of all other class members in the administration of Humanigen’s class action. The lead plaintiff may select a law firm of its choice to conduct the class action. An investor’s ability to share a potential future restoration of the humane…